Showing results (1611-1620 of 3,085) with videos related to
Sort By:
Pageof 309
Drug Safety|September 2, 2008
Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in EnglandRachna Kasliwal, Lynda V Wilton, Saad A W ShakirDrug Safety|September 2, 2008
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysisGerald Gartlehner, Patricia Thieda, Richard A Hansen, et al.Drug Safety|July 19, 2008
Is the principle of a stable Heinrich ratio a myth? A multimethod analysisSteve Gallivan, Katja Taxis, Bryony Dean Franklin, et al.Drug Safety|July 19, 2008
Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS)Emily Jane Woo, Robert Ball, Dale R Burwen, et al.Drug Safety|July 19, 2008
Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ringKim B Handoko, Eugène P van Puijenbroek, Annemarie H Bijl, et al.Drug Safety|October 5, 2021
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015Annette Kjær Ersbøll, Kaushik Sengupta, Eero Pukkala, et al.Drug Safety|June 13, 2019
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy VolunteersJessica Ackert, Khadeeja Mohamed, Jason S Slakter, et al.Drug Safety|October 23, 2021
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label StudyFumihiko Sakai, Norihiro Suzuki, Xiaoping Ning, et al.Drug Safety|February 18, 2022
Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety ReportsCamille Azam, Louis Buscail, Adrian Culetto, et al.Drug Safety|February 3, 2022
Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug AdministrationDavid Croteau, Ellen Pinnow, Eileen Wu, et al.Pageof 309